semaglutide vs glipizide Ozempic : A Comparison Guide 2024 How GLP-1 medications are transforming

10.1016/S0140-6736(05)66456-2 Lancet

The FDA prescribing information for semaglutide and tirzepatide lists nausea, vomiting, diarrhea, constipation, and abdominal pain as frequent adverse reactions

In the SURMOUNT-1 trial, also published in the NEJM , the results were even more striking

Wani, Rahiman, and Almaden (2017) demonstrated that a mice treated with olive oil showed decrease serum total cholesterol, serum triglycerides and low density lipoprotein (LDL) levels as compared animal group fed with high-fat diet

No, current evidence does not show that GLP-1 receptor agonists increase susceptibility to infections

Regulated necrosis: disease relevance and therapeutic opportunities